In Ireland, the last man to be sentenced to death by the horrific process of being ‘hanged, drawn and quartered’ was married ...

Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic cardiomyopathy (HCM), and Biogen CEO ...

Aditya Dhar's much-awaited spy actioner Dhurandhar has released and here's our hoenst review of the Ranveer Singh-starrer.

James Horner’s soundtrack for Mel Gibson’s 'Braveheart,' performed by the London Symphony Orchestra, is getting a 2LP vinyl reissue.

Bristol Myers Squibb currently has the only drug approved specifically for treating obstructive hypertrophic cardiomyopathy, a debilitating disorder that can progress to heart failure. But safety ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It’s one of the largest ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

NEW YORK CITY – Curtis Sliwa says he’s charging into the final stretch of New York City’s mayoral race like "Braveheart" — confident, defiant and ready to die on his sword for the city he loves. In an ...

A weapon used by Mel Gibson while he played the Scots hero of William Wallace in Braveheart has sold for over £8,000 at auction. Fans of the award winning film were given the opportunity to snap up ...

Jiangsu Hengrui Pharmaceuticals has entered into an exclusive licensing agreement with U.S.-based Braveheart Bio for its novel small-molecule cardiac myosin inhibitor, HRS-1893, currently in Phase III ...

Jiangsu Hengrui Pharmaceuticals, a Chinese developer of novel drugs, could receive up to US$1.01 billion in milestone payments after granting a US company exclusive rights to develop a heart disease ...